About us

Endo GI Medical

An innovative Israeli company, privately-owned and backed by NGT3VC.

EndoGI develops systems for plastic stent delivery, enabling drainage of biliary and pancreatic ducts and cysts in one cannulation, while keeping the guide wire in position.

EndoGI’s state-of-the-art delivery systems can position one or more plastic stents in the common bile and hepatic ducts, while securing and maintaining access of the guide wire, after deploying the plastic stent with our proprietary detachable tip, guidewire remains lateral to the plastic stent.

EndoGI received two FDA marketing clearances-510 (k) and regulatory approvals for single and multiple stent delivery systems. We have also launched initial post regulatory approval clinical studies, First in human.

Easy to use

Reduces Complications

Less Time &
Procedural Steps

Fewer Risks


Management Team

Omri Naveh

 Extensive R&D and engineering management, leading products through FDA approvals,
NPI processes and mass production.
Previous companies: Lumenis and ET View.

Ronny Barak
Co-Founder, Chairmen & Strategic BD

25 years Life Science industry experience, from CEO to acquisition, strategic partnership and IPO. 

(CEO at Disc-O-Tech, CollPlant, EndoGun-IBI).

Elad Einav
Co-founder & Director

 10 years R&D, Clinical & Regulatory and management experience, leading products through FDA and CE approvals
to scalability and commercialization (CEO at MediBrane, Biovo).


Majd Saleh
Quality Assurance

15+ years of experience in QA/RA, Medical Engineering and Validation fields in the healthcare industry.

Ensures that the products or services provided by the company are fit for purpose, legally compliant and meet customer expectation by managing the company quality management system.

Shay Yulzary
Mechanical Design

13 years in mechanical design

Shay works for EndoGi as Mechanical Engineering consultant

Employs engineering techniques to deliver  solutions, Proficient CAD  analytical and numerical tools (FE, CFD) , supports full design cycle

Or Targownik
Product Speciallist

5 Years in Clinical support, Sales, business development, Service & project management





Shalom Hazan
R&D Engineering technician

21 years in R&D

Constructs demo systems for marketing needs,

technology development and consulting.

Assists in design transfer

Medical Team

Vote of Confidence by Key Opinion Leaders

Dr. Stanislav Bezobchuk
Chief Gastro Ziv Medical mc

Dr. Stanislav began his career specializing in internal medicine,
and after further specialization in the gastrointestinal field
 developed capabilities in a wide range of fields
 that allow him to contribute from the unique and important
medical knowledge of combining internal medicine
 and the field of gastroenterology
 including invasive therapeutic.

Prof Catalano MEDICAL SAB
Director of UT

Professor of Medicine, Director of  UT-Memorial Hermann Advanced Endoscopy Training Program and Director of UT Community Advanced Gastroenterology Program at the University of Texas Medical School at Houston.
He is Board Certified in Gastroenterology.
He is former Associate Clinical Professor of Medicine at the Medical College of Wisconsin and former Co-Director of Endoscopy at Temple University in Philadelphia.


Board members

Proven Strategic Business Leadership

Zohar Gendler,
Board Director

 CEO of NGT3 VC. Former CEO & director of Beta-O2 (developed implantable bio-artificial pancreas). Served as CEO of the Technion Technological Incubator. Led the establishment and investment of more than 50 companies, such as Prolor Biotech (sold to OPKO, NYSE: OPK), Mazor (NASDAQ: MZOR), Corindus (NASDAQ: CVRS), ReWalk (NASDAQ: RWLK), and others.

Christopher (Chris) Rowland stratigic buisness development advisor

Served as a member of the Medigus Board  and as Chief Executive Officer. served as President of IntraPace Inc. (acquired by PE Company), Mr. Rowland was President and Chief Executive Officer of Neotract Inc. served as President In addition, Chris worked for the Boston Scientific Corporation for seventeen years in positions of increasing responsibility from Sales, Product Development, Marketing, Business Development and General Management.

Skip to content